AI Approach may Help Identify Melanoma Survivors who Face a High Risk of Cancer Recurrence
A team led by investigators at Massachusetts General Hospital (MGH) recently developed an artificial intelligence - based method to predict which patients are most likely to experience a recurrence and are therefore expected to benefit from aggressive treatment.